Pregnancy Preterm
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Pediatrix TherapeuticsChina - Shanghai
1 programContinuous Glucose Monitoring of Late Preterm Birth After CorticosteroidsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pediatrix TherapeuticsContinuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
Human BioSciencesMaternal glycemic control
Clinical Trials (2)
Total enrollment: 86 patients across 2 trials
NCT03738293Pediatrix TherapeuticsContinuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
Start: Dec 2019Est. completion: Dec 20200
N/AWithdrawn
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
Start: Jun 2017Est. completion: Nov 202186 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.